A 36-bp deletion close to the 5 end of NEF that impaired Nef function was found in a long-term nonprogressor with human immunodeficiency virus type 1 (HIV-1) infection. Forms containing an adjacent duplication of 33 bp were also frequently observed. The duplication showed no homology to the deleted region but restored the overall length of the first variable loop of Nef. NEF alleles carrying the duplication were active in class I major histocompatibility complex (MHC-I) down-modulation and enhancement of virus infectivity. However, they showed little activity in CD4 down-regulation and were unable to stimulate viral replication in human peripheral blood mononuclear cells. Our study indicates that the enhancement of virion infectivity and the stimulation of HIV-1 replication in lymphocytes are distinct functions of Nef. Our findings also illustrate the capacity for repair of attenuating deletions in HIV-1 infection and suggest that a selective pressure for Nef-mediated MHC-I down-modulation and/or enhancement of virion infectivity exists.
caques infected with simian immunodeficiency virus (SIV) [5] . Infection with NEF-deleted SIV variants protected monkeys against infection with pathogenic strains [6, 7] . Because of the highly effective protective effects of live attenuated vaccines in the animal model, the use of weakened forms of HIV-1 with deletions in NEF and other genetic elements in small-scale safety trials in humans is under discussion [8, 9] .
To assess the safety of these vaccines and to develop new therapeutic strategies, we feel it is important to understand how Nef enhances viral replication in vivo. Several in vitro activities of Nef that may potentially play a role in the pathogenesis of AIDS have been described. These include an increase in the infectivity of virions [10] [11] [12] ; enhancement of viral replication in human peripheral blood mononuclear cells (PBMC) [10, 11] and in a T-lymphoid rhesus cell line [13] ; down-regulation of CD4 cell-surface expression [14] [15] [16] [17] [18] ; and down-modulation of MHC-I molecules from the cell surface [19, 20] . Multiple effects of Nef on cellular signal transduction pathways and interactions with cellular proteins have also been described [21] [22] [23] [24] [25] . Several of these in vitro activities of Nef are independent [25] [26] [27] [28] , and all may potentially enhance replication and lead to increased virus load in vivo. For example, the enhancement of virus particle infectivity or the activation of the large pool of quiescent T lymphocytes could directly enhance viral spread in vivo. Down-regulation of CD4 may prevent superinfection, promote virus particle release, protect from cytopathic envelope-CD4 interactions, and impair the functions of T helper cells. Finally, down-regulation of MHC-I molecules may allow HIV-1 infected cells to evade cytotoxic T lymphocyte (CTL) lysis. However, the relative importance of these in vitro functions of Nef for viral pathogenesis is unclear.
In this study, we characterized NEF alleles derived from an LTNP with HIV-1 infection who carried highly unusual deletions and duplications close to the 5 end. We found that a 36-bp deletion, which was present in all NEF alleles obtained from this LTNP, completely impaired Nef function in a variety of in vitro assay systems. An adjacent duplication of 33-bp fully restored the ability of Nef to increase virion infectivity and partially restored the ability of Nef to down-modulate MHC-I. However, NEF alleles carrying the duplication were still inactive in CD4 down-regulation and also were unable to stimulate replication in human PBMC. Our study, to our knowledge, represents the first example of the restoration of certain in vitro activities of Nef in HIV-1 infection.
Materials and Methods
Study population. Blood samples were derived from 165 HIV-1 ϩ individuals enrolled into a case-control study of long-term nonprogression in HIV infection, who were followed up by the HIV Epidemiology Unit, Chelsea and Westminster Hospital, London. Patients were categorized into 3 main groups according to their clinical status and CD4 ϩ cell count. Nonprogressors ( ) were n = 47 defined as individuals who had been HIV ϩ for у9 years but who remained asymptomatic and had maintained an absolute CD4 ϩ lymphocyte count 1500/mL. Slow progressors ( ) were defined n = 90 as individuals who had been infected for у9 years but whose CD4 ϩ cell counts had declined !500/mL. Rapid progressors ( ) were n = 28 those who developed AIDS within 5 years of HIV-1 infection.
Case report. Patient 005 is a 44-year-old white homosexual man who first tested HIV-1 ϩ in July 1985. Levels of serum neopterin (10.4 nM/L; ) and B 2 microglobulin (3.2 mg/L; ) NR ! 10 NR ! 2 were slightly elevated in 1993. CD4 ϩ lymphocyte counts have remained at 800-1000 cells/mL for 12 years (figure 1A). HIV-1 RNA levels were quantitated by using the nucleic acid sequence-based amplification assay (Organon Teknika, Durham, NC). Between 15,000 and 55,500 copies of HIV-1 RNA/mL could be detected. The virus load did not increase between 1991 and 1998 (figure 1B). Although the patient had minor ailments, including gingivitis, intermittent diarrhea, and facial warts before 1993, whose relationship to HIV-1 infection is unknown, he currently remains clinically healthy and AIDS-free. He has never received antiretroviral therapy.
DNA and RNA analysis. Proviral NEF-long terminal repeat (LTR) sequences were amplified with a nested polymerase chain reaction (PCR) approach, as described elsewhere [2] , except that different primers were used. The outer primers were VPRF 5 -ATGGAACAAGCMCCRGMAGACCA-3 (5559-5581) or POLU 5 -CCCTAYAACCMCARAGYCARGG-3 (4653-4675) paired with LTRR 5 -GACTACGGCCGTCTGAGGGATCTCT-AGYTACCA-3 (9689-9657); the inner primer pairs were either NOFP 5 -ATACCTASAMGAATMAGACACARGG-3 (8741-8765); NORP 5 -CTGCTTATATGCAGCATCTGAGGG-3 (9510-9487), NEFFP 5 -TAAMATGGGKRGCAAMTGGTC-3 (8783-8803), or NEFRP 5 -AGCAASYTCKRTGTCAGCAGT-3 (9420-9400). Standard abbreviations are used for positions of base ambiguity. Numbers in parentheses refer to the HIV-1 NL4-3 sequence [29] . Proviral DNA copy frequency was estimated by using a modification of the Amplicor HIV-1 test system (Roche Diagnostics Systems, Branchburg, NJ). Cloning and sequencing were performed as described elsewhere [27, 30] . RNA was extracted from 140 mL of plasma by use of the QIAamp Viral RNA kit (Qiagen, Valencia, CA) as recommended by the manufacturer. Reverse transcription was performed by use of primer pF2 5 -CCAGTACA-GGCAAAAAGCAGCTGC-3 (9527-9503), followed by nested PCR, as described elsewhere [2] .
Construction of NEF mutants and expression plasmids. Sitedirected mutagenesis was performed by splice overlap extension PCR [31] . Mutagenic internal primers were used to delete 36 bp that were missing in all 005 NEF genes from the NL4-3 NEF (NL4-3 Del), respectively to insert the corresponding region of the NL4-3 gene into a representative 005 NEF allele (005-Com). These NEF genes and 2 primary 005 NEF alleles, one predicting the 12-amino acid deletion (005-Del) and one with the adjacent duplication (005-Dup), were inserted into a modified pBR322-vector containing the full-length HIV-1 NL4-3 provirus. A mutant of NL4-3 containing a deletion of 260-bp in the NEF-unique region was used as a NEFdefective control (NL4-3 NefϪ). To investigate the ability to stimulate replication in the Herpesvirus saimiri-transformed rhesus T lymphocyte cell line 221 [13] , we generated recombinant chimeras of the SIVmac239 clone containing the NL4-3 NEF gene and the 005 NEF variants by means of standard DNA techniques. For Nef expression in Jurkat T cells, the NEF sequences were amplified by use of primers containing XbaI and MluI restriction sites and subcloned into a T cell-specific pCD3-b expression vector, as described elsewhere [30] . All PCR-derived inserts were sequenced on both strands to confirm that only the intended changes were present.
Cell culture, infectivity, and viral replication assays. 293T and MAGI cells were grown in Dulbecco's modified Eagle medium supplemented with 10% fetal calf serum (FCS). Infection of MAGI cells was performed as described elsewhere [32] . Virus infectivity was quantified by using the Galacto-Light Plus chemiluminescence reporter assay kit (Tropix, Bedford, MA) as recommended by the manufacturer. Human PBMC were isolated by use of lymphocyte separation medium (Organon Teknika). The cells were either prestimulated with phytohemagglutinin (PHA; 4 mg/mL [Sigma]) for 3 d prior to infection or immediately infected with virus stocks containing 2 ng p24 core antigen, kept in RPMI 1640 with 10% FCS, and stimulated with PHA (2 mg/mL) for 3 d at 6 d after infection. After stimulation, the cells were washed and were maintained in RPMI 1640 medium supplemented with 20% FCS and 50 U/mL interleukin (IL)-2. The H. saimiri-transformed T cell line 221 [13] was maintained in the presence of 100 U IL-2/mL (Boehringer, Heidelberg, Germany) and 20% FCS, and infections were performed in the presence of 50 U IL-2/mL and 5% FCS. Supernatants were collected at 3-or 4-d intervals, and virus production was measured by reverse transcriptase (RT) assay as described elsewhere [33] . Virus stocks were generated by transient transfection of 293T cells by the calcium phosphate method with proviral constructs, as described elsewhere [34] , and the p24 antigen levels were quantified by using a commercial HIV-1/HIV-2 ELISA (Immunogenetics, Zwijndrecht, Belgium).
Viral antigen expression in infected cells. CEMϫ174 cells were infected with virus containing 25 ng p24 core antigen derived from transfected 293T cells. When cytopathic effects were observed, cells were labeled and lysates were generated, as described elsewhere [35] . Lysates were incubated with sera from HIV-1 ϩ individuals or with a polyclonal goat anti-Nef serum, and radioimmunoprecipitation assay and SDS-PAGE were performed as described elsewhere [35] . The amounts of precipitated p24 and Nef were quantitated by using a phosphoimager (Fujix Bas2000 phosphoimager; Raytest, Straubenhardt, Germany).
Biochemical analysis. Dose response analysis of the effect of Nef on CD4 and MHC-I cell surface expression was assayed as described elsewhere [26, 28] . Briefly, CD4
ϩ Jurkat T cells were cotransfected by electroporation with a CMV CD20 marker plasmid and various amounts of Nef expression plasmid and carrier DNA. At 30-36 h after transfection, cells were incubated for 1 h on ice with PerCP-conjugated anti-CD20 monoclonal antibody (MAb; Leu-16; Becton Dickinson, Heidelberg, Germany), and a phycoerythrin-conjugated anti-CD4 MAb (Leu3A, Becton Dickinson) together with a fluorescein isothiocyanate-conjugated anti-HLA A,B,C MAb (G46-2.6; PharMingen, Hamburg, Germany). The levels of CD4 and class I MHC were represented as the peak channel number of red or green fluorescence on CD20 ϩ cells, by use of an Epics-Elite flow cytometer (Beckman, Fullerton, CA).
Results
Sequence abnormalities in 005 NEF alleles. We previously found deletion of NEF genes in 1 of 5 HIV-1 ϩ LTNPs analyzed [2] . In comparison, only 1 of 161 positive PCR reactions, among the 165 HIV-1 ϩ individuals analyzed in the present study, yielded amplification products slightly smaller than expected for a full-length NEF gene (data not shown). PCR analysis of DNA prepared from PBMC obtained from patient 005 from 1993 through 1997 revealed a variety of length variations in the 5 half of NEF. Most forms migrated faster than amplification products obtained from the standard NL4-3 NEF gene (figure 2). Sequence analysis of entire NEF genes revealed that all sequences predicted a deletion of amino acids 26-37, compared with the NL4-3 Nef and other published Nef amino acid sequences (figure 3). The deleted region is located just downstream of a previously defined length-variable region in NEF and is usually highly conserved [29] . In contrast, sequence analysis of ∼4.5 kb of the 3 half of the proviral genome revealed that no deletions or insertions were present in the ENV, VIF, TAT, REV, VPR, and VPU genes or in the LTR. Furthermore, the deduced amino acid sequences did not reveal unusual substitutions, compared with published HIV-1 protein sequences (data not shown). Interestingly, several NEF sequences predicted an adjacent duplication of amino acids 43-53. Similar deletions or duplications have not been detected in other NEF sequences [29] . The duplication (ITSSNTAANNA) shows little homology to the deleted region (AADGVGAVSRDL) but restores the overall length of the first variable loop of the HIV-1 Nef protein. It was present in only a minor fraction of the NEF alleles amplified from the 1993 and 1994 samples but predominated in February 1996 (figure 3). Analysis of a PBMC sample obtained in 1997 revealed an even larger direct repeat of 51-bp, predicting duplication of amino acids 43-59 (figure 3) .
To investigate whether similar sequence variations in NEF were also present in the viral RNA species, we performed RT- The viral RNA and DNA burdens were both relatively high compared with those of other LTNPs, in which only defective forms of NEF were detected [2] [3] [4] . Measurement of proviral DNA in PBMC indicated that proviral sequences were present at frequencies of 134 and 196 copies/mg DNA in May and September 1996. The RNA copy numbers varied between 10,000 and 50,000/mL (figure 1B). Independent PCR reactions from the same plasma or PBMC samples yielded similar patterns of amplification products (data not shown).Thus, PCR amplification products should result from representative DNA or RNA copy numbers. However, fragments of different lengths were amplified from the corresponding plasma and PBMC samples (figure 2). Sequence analysis confirmed that the major proviral DNA species detected in PBMC differed from the major viral RNA species (figure 3). Overall, forms of NEF predicting duplication of amino acids 43-53 were more frequently observed in RNA-derived sequences (figure 3 and data not shown).
Expression of 005-NEF alleles. Five Nef variants were used to assess the functional relevance of the unusual deletions and duplications observed in NEF alleles derived from patient 005: (1) the functional wild-type NL4-3 NEF allele; (2) an NL4-3 First, these NEF alleles were inserted into the backbone of the molecular HIV-1 NL4-3 clone. Normalized amounts of the proviral NL4-3 constructs, differing only in the specific changes in NEF, were transfected into 293T cells to generate virus stocks by transient expression. The virus stocks were used to infect CEMϫ174 cells. All NL4-3 NEF variants replicated with similar kinetics in this T/B hybrid cell line (data not shown). At 1 week after infection, when giant-cell formation was observed, the cells were metabolically labeled. Viral proteins were immunoprecipitated from aliquots of the cellular extracts by using 2 sera from HIV-1 ϩ individuals and a Nef-specific antiserum (figure 4). Similar amounts of structural viral proteins were detected (figure 4 and data not shown). NL4-3 and 005 Nef proteins were readily detectable in 1 of the 2 patient sera (figure 4, top) and the Nef-specific antiserum ( figure 4, bottom) . In contrast, no Nef-specific signal could be detected in extracts from CEMϫ174 cells infected with NEF-deleted virus (NL4-3 NefϪ; figure 4) . However, relative to the amount of p24 antigen, about 4-fold lower amounts of Nef protein were detected in cells infected with the variant carrying the NL4-3 Del NEF allele. Nef protein levels were also slightly reduced in cells infected with the 005-Del variant but not in cells infected with the 005-Dup or 005-Com variants (figure 4). For 005-Del and 005-Dup, 2 specific bands were observed (figure 4). These slight differences in migration may result from different phosphorylation levels [36] . Although the 12-amino acid deletion seems to decrease the stability of the NL4-3 Nef, the amounts of the 3 different 005-Nef proteins differed !2-fold from the wild-type NL4-3 Nef protein in the infected cells. Therefore, we next studied Nef function in a variety of in vitro assay systems.
The duplication restores the ability of NEF to increase virion infectivity. An intact HIV-1 NEF gene increased virus infectivity for MAGI cells ∼3-4 fold (figure 5). The 005-Del Nef was inactive in this assay, and deletion of the corresponding region in the NL4-3 NEF gene also impaired the enhancement of infectivity (figure 5). The ability of Nef to enhance virion infectivity was fully restored when the deletion was repaired by the insertion of the corresponding NL4-3 NEF region (005-Com). The 005-Dup NEF allele with the downstream dupli- The 005 NEF alleles are unable to stimulate viral replication in lymphocytes. The same virus stocks used for quantitation of virion infectivity in MAGI cells were utilized to assess the influence of the deletion and duplication in 005 Nef on viral replication in human PBMC. All Nef variants replicated efficiently in prestimulated PBMC (figure 6A). However, only the parental HIV-1 NL4-3 replicated efficiently when PBMC were infected at low multiplicity immediately after isolation and were stimulated 6 d later (figure 6B). Thus, neither duplication nor repair of the deletion restored functional activity in this assay, indicating that additional inactivating point mutations are present in 005 NEF alleles. The observed differences between the ability of the NEF variants to enhance virion infectivity and to stimulate replication in PBMCs suggest that both activities are independent Nef functions. To confirm this unexpected result, we utilized the T-lymphoid rhesus macaque cell line 221 [13] . In the presence of low amounts of IL-2, functional Nef expression causes 221 cell activation, resulting in enhanced viral replication. We generated SIVmac chimeras containing the HIV-1 NEF alleles of interest. The use of chimeric viruses was necessary because HIV-1 does not replicate in 221 cells, and a similar system for HIV-1 is not available. The chimeric form containing the NL4-3 NEF allele replicated with kinetics similarly to the parental SIVmac239 NEF-open variant ( figure 6C ). However, in agreement with the results obtained with PBMC, all other HIV-1 NEF alleles were unable to stimulate viral replication.
The duplication partly restores Nef-mediated down-regulation of MHC-I, but not of CD4 molecules. A subline of human Jurkat T cells expressing high levels of CD4 [28] was transiently transfected with plasmids expressing the various Nef proteins.
CD4 and MHC-I surface expression on the transfected cells were measured simultaneously. Expression of the NL4-3 Nef resulted in a down-regulation of CD4 cell surface expression of ∼20-fold (figure 7A). Deletion of amino acids 25-36 completely disrupted this Nef function. Also the 005-Com and 005-Dup NEF alleles showed only marginal activity, even at the highest concentration of Nef expression plasmid ( figure 7A) . Accordingly, the deleted region is important for the ability of Nef to down-regulate CD4, but, similar to the enhancement of viral replication in lymphocyte cultures, additional changes in 005 NEF alleles impair functional activity in this assay. Expression of NL4-3 Nef results in a reduction of cell surface expression of MHC-I molecules of ∼10-fold ( figure 7B ). This effect was dose dependent and did not saturate even at the highest concentration of 20 mg Nef expression plasmid. The 12-amino acid deletion impaired NL4-3 Nef activity in this assay, and the 005-Del Nef showed only marginal activity (figure 7B) . In contrast, the insertion of the 12 missing amino acids in the 005-Nef (005-Com) fully restored the ability of Nef to down-regulate MHC-I molecules from the cell surface ( figure  7B ). Also the 005-Dup Nef down-modulated MHC-I, albeit with reduced efficiency compared with the NL4-3 and 005-Com NEF alleles.
Discussion
Thus far, 9 HIV-1 ϩ LTNPs have been described in whom only deleted forms of NEF could be detected [2] [3] [4] . In all these patients, large nonrevertible deletions, which completely disrupted the NEF open-reading frame, were present. In contrast, the NEF alleles derived from patient 005 contained a smaller in-frame deletion of only 36 bp. Similar to previous reports on infection with NEF-defective HIV-1, this study found that pa- ϩ cells. The amount of Nef expression vector DNA is indicated on the abscissa. CD4, CD20, and MHC-I expression on the cell surface were determined simultaneously from the same transfection by 3-color flow-cytometric analysis [26] . Western blot analysis confirmed comparable transfection efficiencies of the different constructs (not shown). Ⅵ, NL4-3 Nefϩ; Ⅺ, NL4-3 Del; ᭡, 005-Del; ᭝, 005-Com; ࡗ, 005-Dup; ⅷ, vector control. tient 005 shows stable CD4 ϩ T cell counts and no disease progression despite 112 years of infection. No sequence abnormalities were detected in other regions of the viral genome, suggesting that the deleted region in NEF is important for HIV-1 replication in vivo. However, the 005 NEF alleles seem to have some residual activity in vivo, because the rest of the openreading frame remained intact and the viral RNA load seemed high for NEF-defective HIV-1 infection.
In in vitro assay systems for Nef function, a representative 005 NEF allele carrying the 12-amino acid deletion was inactive in CD4 and MHC-I down-regulation and also unable to increase virus infectivity and replication. Deletion of the corresponding amino acids 25-36 in NL4-3 Nef completely disrupted all assayed in vitro functions, providing further evidence for the importance of this region in Nef. The repair of this deletion by an adjacent duplication selectively restored functional activity in MHC-I down-regulation and enhancement of infectivity. This is the first case of HIV-1 infection in humans in which a defective NEF gene was partially repaired by adjacent duplication. However, repair of a smaller deletion of 12 bp in the NEF gene of SIVmac, by duplication and subsequent point mutations that restored functional activity, has been described elsewhere [37, 38] . The repair of this NEF deletion occurred only in a small subset of infected macaques and coincided with increasing virus load and progression to immunodeficiency [37] .
In contrast to the findings in the SIV/macaque model, the levels of CD4 ϩ lymphocytes in patient 005 remained stable, and the virus load did not increase throughout the observation period. Furthermore, we did not observe an accumulation of point mutations in the duplicated region that reconstituted a wild-type-like sequence and fully restored Nef function. One possible explanation is that too many nucleotide changes are required to restore the ability of 005 NEF alleles to downmodulate CD4 and to stimulate viral replication in lymphocytes. However, it is also conceivable that more active HIV-1 Nef variants have only a temporary growth advantage in patient 005, because forms that replicate more efficiently should induce stronger specific antiviral immune responses that may result in the subsequent elimination of these variants. Highly effective control of HIV-1 replication may also explain why variants with duplications in Nef did not continuously outgrow forms without restorative alterations. The rapid changes of the viral RNA species are in agreement with a high selective pressure for different virus populations. Although a strong selective advantage in vivo for intact functional forms of NEF exists [5] , a high frequency of defective NEF alleles late in infection of an HIV-1 LTNP, who showed a highly efficient antiviral immune response, has been described [30] .
Most previous cases of HIV-1 infections in which only defective forms of NEF could be detected seem to have resulted from initial infections with variants containing large nonreversible deletions in NEF [2, 3] . The earliest blood sample available from patient 005 postdated HIV infection by at least 6 years. Therefore, it is unclear whether he was initially infected with an HIV-1 variant containing the 12-amino acid deletion in Nef. It has been described that CTL responses directed against Nef may lead to the selection of Nef variants and to the emergence of escape mutants [39] [40] [41] . The deleted region in 005-Nef does not represent a known CTL epitope. Nonetheless, it seems possible that the 12-amino acid deletion in Nef was initially selected to escape a strong CTL response.
The 12-amino acid deletion had pleiotropic effects and disrupted all in vitro functions of Nef analyzed. In comparison, in vivo selected NEF alleles predicting the adjacent duplication of 11 amino acids (005-Dup Nef) and the constructed 005-Com Nef, in which the deleted region was repaired by insertion of the corresponding region in the NL4-3 Nef, had interesting in vitro properties. Both Nef variants were inactive in CD4 downmodulation but down-regulated cell surface expression of MHC-I molecules. Our observation confirms a recent report by Greenberg et al. [28] indicating that Nef-mediated endocytoses of MHC-I and CD4 molecules are separable functions of Nef. The 005-Com and 005-Dup Nef proteins enhanced the infectivity of HIV-1 particles for MAGI cells to the same extent as NL4-3 Nef. However, both NEF alleles did not stimulate viral replication in human PBMC or in 221 cells. Our results suggest that the effect of Nef on particle infectivity does not account for the enhanced growth kinetics of HIV-1 containing a functional NEF gene in primary lymphocyte culture. It seems likely that the increased replication of Nef ϩ viruses in PBMC is due to lymphoid cell activation. This assumption would also explain why the enhanced replication kinetics of NEF-open viruses are predominantly observed when PBMC are infected immediately after isolation and are stimulated several days later but not in prestimulated lymphocyte cultures or in most immortalized T cell lines. The finding that a 36-bp deletion in HIV-1 NEF can be partially repaired by an adjacent duplication further emphasizes the importance of using large deletions in multiple genetic elements in live attenuated HIV vaccines.
In summary, our results suggest that amino acids 25-36 in HIV-1 Nef are important both for several well-defined in vitro functions of Nef and for the pathogenicity of HIV-1 in humans. It seems that a selective pressure to restore Nef's ability to enhance virus particle infectivity and/or to mediate down-regulation of MHC-I molecules exists in vivo. The lack of disease progression in patient 005 may be explained by highly effective immune control, but it also indicated that Nef-mediated CD4 down-regulation and/or enhanced replication in lymphocytes contributes to the full pathogenic potential of HIV-1.
